Study of ODX (OsteoDex) in Multiple Myeloma
Study of ODX (OsteoDex) in Multiple Myeloma
Recruiting · NCT06616389 · Registry updated 2025-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ODX (OsteoDex) in Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2025-08-19 | NCT06616389 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| DexTech Medical AB | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Karolinska Universitetssjukhuset Huddinge Cancerstudieenheten M62 | Stockholm | Sweden | 1 |
| Uddevalla Sjukhus, Hematologens dagvård | Uddevalla | Sweden | 1 |